JP7142022B2 - Malt1の阻害剤およびそれらの使用 - Google Patents
Malt1の阻害剤およびそれらの使用 Download PDFInfo
- Publication number
- JP7142022B2 JP7142022B2 JP2019549411A JP2019549411A JP7142022B2 JP 7142022 B2 JP7142022 B2 JP 7142022B2 JP 2019549411 A JP2019549411 A JP 2019549411A JP 2019549411 A JP2019549411 A JP 2019549411A JP 7142022 B2 JP7142022 B2 JP 7142022B2
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- unsubstituted
- substituted
- alkenyl
- alkynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762468758P | 2017-03-08 | 2017-03-08 | |
| US62/468,758 | 2017-03-08 | ||
| US201762553336P | 2017-09-01 | 2017-09-01 | |
| US62/553,336 | 2017-09-01 | ||
| PCT/US2018/021481 WO2018165385A1 (en) | 2017-03-08 | 2018-03-08 | Inhibitors of malt1 and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020511454A JP2020511454A (ja) | 2020-04-16 |
| JP2020511454A5 JP2020511454A5 (cg-RX-API-DMAC10.html) | 2021-04-15 |
| JP7142022B2 true JP7142022B2 (ja) | 2022-09-26 |
Family
ID=63448912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019549411A Active JP7142022B2 (ja) | 2017-03-08 | 2018-03-08 | Malt1の阻害剤およびそれらの使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11248007B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3592731A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7142022B2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2018165385A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3736277A1 (en) * | 2016-07-29 | 2020-11-11 | Lupin Limited | Substituted thiazolo-pyridine compounds as malt1 inhibitors |
| WO2018020474A1 (en) * | 2016-07-29 | 2018-02-01 | Lupin Limited | Substituted thiazolo-pyridine compounds as malt1 inhibitors |
| TWI795381B (zh) | 2016-12-21 | 2023-03-11 | 比利時商健生藥品公司 | 作為malt1抑制劑之吡唑衍生物 |
| BR112021009994A2 (pt) * | 2018-11-28 | 2021-08-17 | Takeda Pharmaceutical Company Limited | composto, e, medicamento |
| KR102982241B1 (ko) * | 2019-03-12 | 2026-06-25 | 오르토-클리니칼 다이아그노스틱스, 인코포레이티드 | 자가항체 검출용 조성물, 키트, 및 방법 |
| US12404260B2 (en) * | 2019-04-11 | 2025-09-02 | Janssen Pharmaceutica Nv | Pyridine rings containing derivatives as MALT1 inhibitors |
| TW202115077A (zh) * | 2019-07-01 | 2021-04-16 | 大陸商上海齊魯銳格醫藥研發有限公司 | Malt1抑制劑及其用途 |
| EP4163280A4 (en) * | 2020-05-27 | 2024-06-05 | Takeda Pharmaceutical Company Limited | METHOD FOR PRODUCING A HETEROCYCLIC COMPOUND |
| JP2023549835A (ja) * | 2020-11-12 | 2023-11-29 | モノプテロス セラピューティクス,インコーポレーテッド | がんを治療する材料及び方法 |
| EP4284804A1 (en) | 2021-01-26 | 2023-12-06 | Schrödinger, Inc. | Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disorders |
| JP2025501056A (ja) | 2021-12-30 | 2025-01-17 | シャンハイ ハンソー バイオメディカル カンパニー リミテッド | 三環系誘導体阻害剤、その製造方法と応用 |
| JP2026510946A (ja) * | 2023-03-17 | 2026-04-10 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | レチンアルデヒドデヒドロゲナーゼ1(raldh1)阻害剤および免疫賦活剤の組み合わせならびにそれらの使用方法 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5596001A (en) | 1993-10-25 | 1997-01-21 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)quinoline derivatves |
| WO2014086478A1 (en) | 2012-12-03 | 2014-06-12 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Inhibitors of malt1 protease |
| WO2015181747A1 (en) | 2014-05-28 | 2015-12-03 | Novartis Ag | Novel pyrazolo pyrimidine derivatives and their use as malt1 inhibitors |
| JP2015536990A (ja) | 2012-11-09 | 2015-12-24 | コーネル・ユニバーシティーCornell University | Malt1の低分子阻害剤 |
| JP2019522035A (ja) | 2016-07-29 | 2019-08-08 | ルピン・リミテッド | Malt1阻害剤としての置換チアゾロ−ピリジン化合物 |
| JP2019537599A (ja) | 2016-11-01 | 2019-12-26 | コーネル ユニバーシティー | Malt1分解のための化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9090592B2 (en) * | 2010-12-30 | 2015-07-28 | AbbVie Deutschland GmbH & Co. KG | Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| GB2504550A (en) | 2012-08-03 | 2014-02-05 | Nanyang Polytechnic | Diarylurea compound PQ401 for inhibiting the growth and/or proliferation of cancer stem cells |
-
2018
- 2018-03-08 EP EP18763780.6A patent/EP3592731A4/en not_active Withdrawn
- 2018-03-08 WO PCT/US2018/021481 patent/WO2018165385A1/en not_active Ceased
- 2018-03-08 JP JP2019549411A patent/JP7142022B2/ja active Active
- 2018-03-08 US US16/492,066 patent/US11248007B2/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5596001A (en) | 1993-10-25 | 1997-01-21 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)quinoline derivatves |
| JP2015536990A (ja) | 2012-11-09 | 2015-12-24 | コーネル・ユニバーシティーCornell University | Malt1の低分子阻害剤 |
| WO2014086478A1 (en) | 2012-12-03 | 2014-06-12 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Inhibitors of malt1 protease |
| WO2015181747A1 (en) | 2014-05-28 | 2015-12-03 | Novartis Ag | Novel pyrazolo pyrimidine derivatives and their use as malt1 inhibitors |
| JP2019522035A (ja) | 2016-07-29 | 2019-08-08 | ルピン・リミテッド | Malt1阻害剤としての置換チアゾロ−ピリジン化合物 |
| JP2019537599A (ja) | 2016-11-01 | 2019-12-26 | コーネル ユニバーシティー | Malt1分解のための化合物 |
Non-Patent Citations (1)
| Title |
|---|
| Journal of Chemical Information and Modeling,2011年,Vol. 51, No. 6,pp. 1474-1491 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3592731A4 (en) | 2020-10-07 |
| EP3592731A1 (en) | 2020-01-15 |
| WO2018165385A1 (en) | 2018-09-13 |
| JP2020511454A (ja) | 2020-04-16 |
| US11248007B2 (en) | 2022-02-15 |
| US20200385405A1 (en) | 2020-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7097880B2 (ja) | Malt1分解のための化合物 | |
| US11248007B2 (en) | Inhibitors of MALT1 and uses thereof | |
| JP7258748B2 (ja) | サイクリン依存性キナーゼ12(cdk12)の阻害剤およびその使用 | |
| JP7308146B2 (ja) | インターロイキン1受容体関連キナーゼの阻害剤およびその使用 | |
| CN113993519B (zh) | 细胞周期蛋白依赖性激酶12(cdk12)的降解剂及其用途 | |
| JP7785108B2 (ja) | 血漿カリクレインの阻害剤およびその使用 | |
| EP3876939A1 (en) | Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof | |
| JP7675070B2 (ja) | 治療、特にmyd88変異疾患における使用のためのhck阻害剤としてのピラゾロピリミジン誘導体 | |
| EP4377306A1 (en) | Rock2 inhibitors and uses thereof | |
| US12590084B2 (en) | Oxadiazole HDAC6 inhibitors and uses thereof | |
| JP2025539828A (ja) | Ripk2の阻害剤及びその医学的使用 | |
| JP7185631B2 (ja) | 抗線維化化合物 | |
| JP2019505548A (ja) | Mycモジュレーターとしてのmaxバインダーおよびこれらの使用 | |
| WO2023150203A1 (en) | Hdac6 inhibitors and uses thereof | |
| EA052549B1 (ru) | Ингибиторы rock2 и их применение | |
| CN118055926A (zh) | Rock2抑制剂及其用途 | |
| WO2017218874A1 (en) | Hedgehog acyltransferase inhibitors and uses thereof | |
| CA2972239A1 (en) | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210305 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210305 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220105 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220106 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220405 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220509 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220804 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220902 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220912 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7142022 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |